Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial

Dengue is a mosquito-borne viral disease that is endemic in India. We evaluated the immunogenicity and safety of recombinant, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in Indian adults. In this observer-blind, randomized, placebo-controlled, Phase II study, adults aged 18–45 years were r...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Dubey, Anand Prakash, Agarkhedkar, Sharad, Chhatwal, Jugesh, Narayan, Arun, Ganguly, Satyabrata, Wartel, T Anh, Bouckenooghe, Alain, Menezes, Josemund
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2015
Aiheet:
Research Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5049724/
https://ncbi.nlm.nih.gov/pubmed/26291554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1076598
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia